Abstract
Immune checkpoint inhibitors (ICIs) represents a key stone of cancer treatment, including non-small cell lung cancer. Unfortunately, the efficacy of ICIs is poor in patient with bone metastases from NSCLC. Recently, several case reports have suggested the abscopal effect of radiotherapy in advanced NSCLC patients. However, whether this positive abscopal effect is applicable during ICIs treatment of NSCLC involving bones, remains to be established.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
